The landscape of managing diabetes is advancing with the arrival of transdermal GLP-1 delivery . These novel patches offer a potentially less invasive alternative to shots for individuals living with type 2 diabetes . These patches deliver a GLP-1 agonist directly through the dermis , avoiding th